L-Carnitine L-Tartrate in Preventing Peripheral Neuropathy Caused By Chemotherapy in Women With Metastatic Breast Cancer

Stopped early · Phase 4 · Has a placebo group

Conditions studied: Breast Cancer, Chemotherapeutic Agent Toxicity, Neurotoxicity

In brief

RATIONALE: L-carnitine L-tartrate may prevent peripheral neuropathy caused by chemotherapy. PURPOSE: This randomized clinical trial is studying how well L-carnitine L-tartrate works in preventing peripheral neuropathy caused by chemotherapy in women with metastatic breast cancer.

Key facts

Study ID

NCT00754767

Run by

HealthPartners Institute

People needed

2

Starts

2007-01-02

Expected to finish

2008-05-02

Last updated by the study team

2017-09-11

Who can join

Age: 18 and older, up to 120. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Masonic Cancer Center at University of Minnesota — Minneapolis, Minnesota, United States
• Park Nicollet Cancer Center — Saint Louis Park, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.